Cargando…

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study

OBJECTIVE: Despite the demonstrated benefits of glucagon-like peptide 1 (GLP-1) receptor agonist therapy, adherence and persistence with this therapy is often challenging. The purpose of this study was to expand current understanding of patients’ experiences, motivations, and challenges relevant to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polonsky, William, Gamble, Cory, Iyer, Neeraj, Martin, Mona, Hamersky, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178715/ https://www.ncbi.nlm.nih.gov/pubmed/34149258 http://dx.doi.org/10.2337/ds20-0025

Ejemplares similares

Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes
por: Hamersky, Carol M., et al.
Publicado: (2019)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Why do children still have preventable caries?
por: Kazmi, Alizey, et al.
Publicado: (2021)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes—So Why Is Their Uptake So Low?
por: King, Aaron, et al.
Publicado: (2023)

Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions
por: Lin, Min, et al.
Publicado: (2021)

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
por: Aroda, Vanita R., et al.
Publicado: (2018)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
por: Skolnik, Neil, et al.
Publicado: (2018)

Why Do Delusions Persist?
por: Corlett, Philip R., et al.
Publicado: (2009)

The Role of the Lecturer as Tutor: Doing What Effective Tutors Do in a Large Lecture Class
por: Wood, William B., et al.
Publicado: (2012)

What roles do middle managers play in implementation of innovative practices?
por: Engle, Ryann L., et al.
Publicado: (2017)

What's a Poison Got to Do with It?
por: Vázquez, José
Publicado: (2010)

Where Do New Medicines Come From?
por: Liu, Dennis
Publicado: (2011)

Oral cancer: We can do better - now
Publicado: (2020)

What to do if you receive a negligence claim
por: Barnes, Greta
Publicado: (2021)

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
por: Wysham, Carol H., et al.
Publicado: (2018)

Do your patients' expectations match your clinical view?
por: Williams, Michelle
Publicado: (2022)

DO SOME PEOPLE HAVE NATURALLY STRONGER IMMUNE SYSTEMS?
por: Wilson, Clare
Publicado: (2023)

The incompletely fulfilled promise of embryo transfer in cattle—why aren’t pregnancy rates greater and what can we do about it?
por: Hansen, Peter J
Publicado: (2020)

NHS and private principal net profit: What do associates think?
por: Westgarth, David
Publicado: (2022)

Ten things dental students can do to support LGBT+ patients
Publicado: (2021)

Evidence-based practice and patient-centered care: Doing both well
por: Engle, Ryann L., et al.
Publicado: (2021)

HPV and head and neck cancer: Are we doing enough to raise awareness?
por: Westgarth, David
Publicado: (2022)

COVID-19: What to do if you're worried about a child
por: Foster, Mark
Publicado: (2020)

Do different uses of performance measurement systems in hospitals yield different outcomes?
por: van Elten, Hilco J., et al.
Publicado: (2021)

Mentoring: Why now?
por: Saw, Mabel, et al.
Publicado: (2021)

Stem Cell Promise, Interrupted: How Long Do US Researchers Have to Wait?
por: Gross, Liza
Publicado: (2007)

Are dental schools doing enough to prepare dental hygiene & therapy students for direct access?
por: D. D. Quach, Joshua, et al.
Publicado: (2020)

How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
por: Kim, Sookyung, et al.
Publicado: (2022)

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)
por: Polonsky, William H., et al.
Publicado: (2021)

Why is phishing still successful?
por: Bhardwaj, Akashdeep, et al.
Publicado: (2020)

Why is exercise important to dentistry?
por: Pushparatnam, Rishiniy
Publicado: (2021)

Specialist training in Fiji: Why do graduates migrate, and why do they remain? A qualitative study
por: Oman, Kimberly M, et al.
Publicado: (2009)

Where Do We Go From Here?: The Impact of COVID-19 on Practice Readiness and Considerations for Nurse Leaders
por: Grubaugh, Martha, et al.
Publicado: (2022)

Use of Glucagon in Patients With Type 1 Diabetes
por: Haymond, Morey W., et al.
Publicado: (2019)

Do local economic interests matter when regulating nationally significant infrastructure? The case of renewable energy infrastructure projects
por: Rydin, Yvonne, et al.
Publicado: (2018)

Why are women dying in India’s sterilisation camps?
por: Pulla, Priyanka
Publicado: (2014)

Vitamins and supplements - why choice and context are key
por: Lloyd-Rees, Kimberley
Publicado: (2021)

Why student problems matter to the entire profession
por: Westgarth, David
Publicado: (2022)

Why Not the Best? How Science Failed the Florida Panther
por: Gross, Liza
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_uekbqolopk4jpu72djibrq8bqh